NCT04372641 2025-09-17
Testing the Safety of CB-5339 in Patients With Cancer
National Cancer Institute (NCI)
Phase 1 Withdrawn
Clinical Trials
4 trialsNCT06161558 2025-07-16
Erlotinib in Combination With Select Tyrosine Kinase Inhibitors in Adult Patients With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Withdrawn
NCT02874053 2019-06-19
The Role of Emotions and Regulatory Focus in Decision Making That Involves Risk Tradeoffs
National Institutes of Health Clinical Center (CC)
Withdrawn
NCT00166686 2013-01-11
Clonidine for Neurocognitive Sequelae
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Phase 1/2 Withdrawn